Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Aug 26, 2022--
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Aug 26, 2022--